Hexagon Nutrition IPO
ListedMainboardOpens 5 June 2026Closes 9 June 2026
Hexagon Nutrition Limited, incorporated in 1993, is a research-focused clinical nutrition and food-science enterprise. The company is engaged in the development, manufacturing, and marketing of high-value micronutrient…
Hexagon Nutrition Limited, incorporated in 1993, is a research-focused clinical nutrition and food-science enterprise. The company is engaged in the development, manufacturing, and marketing of high-value micronutrient premixes, branded clinical nutrition wellness lines, therapeutic formulations, and ready-to-use nutritional foods (RUFs). Hexagon operates three advanced industrial manufacturing hubs in India (Nasik, Chennai, and Thoothukudi) along with an international factory setup in Tashkent, Uzbekistan. Its Chennai and Thoothukudi facilities are strategically positioned within Special Economic Zones (SEZs) to optimize export logistics and secure duty-free raw material imports.
Show moreShow less
Key ratios
As per RHP / filingsTimeline
IPO Opens
5 Jun
IPO Closes
9 Jun
Allotment
10 Jun
Listing
12 Jun
IPO Timeline & Listing Details
| Event | Date |
|---|---|
| IPO Open Date | 5 June 2026 |
| IPO Close Date | 9 June 2026 |
| Allotment Date | 10 June 2026 |
| Listing Date | 12 June 2026 |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Retail (Min) | 1 | ₹14,985 |
Retail (Max)Just less than ₹2,00,000 | 13 | ₹1,94,805 |
SHNI (Min)Just above ₹2,00,000 | 14 | ₹2,09,790 |
SHNI (Max)Below ₹10,00,000 | 66 | ₹9,89,010 |
BHNIAbove ₹10,00,000 | 67 | ₹10,03,995 |
IPO Reservation Details
| Category | Reservation |
|---|---|
| QIB (Qualified Institutional Buyer) | 50.00% |
| NII (Non-Institutional Investor) | 15.00% |
| SHNI (Small Non-Institutional Investor) | 5.00% |
| BHNI (Big Non-Institutional Investor) | 10.00% |
| Retail | 35.00% |
| Total | 100.00% |
IPO Objectives
- The IPO is entirely an Offer for Sale (OFS) of 3,08,59,704 equity shares by the existing promoter and investor selling shareholders. The company will not receive any direct capital proceeds from the public issue.
- To achieve the benefits of listing the equity shares on the stock exchanges (BSE and NSE) to enhance brand visibility and provide liquidity to shareholders.
Strengths
- The company has established a Differentiated Research Product Niche, building a strong research-driven portfolio that crosses premium clinical nutrition brands (Pentasure, Obesigo, Pediagold) and specialized institutional micronutrient premixes.
- It benefits from a Strategic Global Manufacturing Moat, operating four advanced production units spread across India and Uzbekistan, including two optimized Indian SEZ nodes that minimize import duty friction.
- The business leverages an Expansive Omnichannel Network, reaching wide consumer demographics via 342 domestic retail distributors alongside pharmacy chains, hospital channels, and proprietary digital storefronts.
- It commands a Deep Global Export Base, successfully scaling its clinical and wellness nutritional distribution corridors across more than 75 international boundaries spanning Europe, Africa, and South America.
- The firm maintains a Healthy Balance Sheet, keeping highly conservative leverage limits with a comfortable debt-to-equity layer tracking at just 0.18 as of late 2025.
Weaknesses
- The public issue is structured as a Pure Offer for Sale (OFS) of ₹138.87 Cr, consisting entirely of shares sold by existing promoters, which yields zero fresh corporate capital infusion to fund internal facility expansions or new asset rollouts.
- The business faces Fragile Global Regulatory Exposure, being subject to strict multi-nation healthcare certifications and rigorous quality verifications where any sudden compliance lapse could severely impact export volumes.
- The issue is met with a Quiet Unofficial Gray Market reception, with early Grey Market Premium (GMP) indicators tracking flat at ₹0, signaling highly cautious or cold retail participant sentiment ahead of the launch window.
Financial Performance
| Period Ended | 31 Dec 2025 (9M) | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets (₹ Cr.) | 327.6 | 261.36 | 250.54 | 288.9 |
| Revenue (₹ Cr.) | 275.57 | 331.29 | 304.62 | 281.65 |
| PAT (₹ Cr.) | 27.03 | 24.38 | 12.21 | 5.82 |
| Net Worth (₹ Cr.) | 223.05 | 195.6 | 176.29 | 163.84 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Hexagon Nutrition | 2.48 | 15.35 | 13.02% | 223.05 |
| Nestle India Ltd | 53.2 | 78.39 | 67.85% | 4,010.02 |
| Zydus Wellness Ltd | 2.77 | 81.73 | 3.98% | 5,672.25 |
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0x | 0.17x | 19.77x |
| NII | 2.03x | 6.7x | 161.49x |
| S-HNI | 3.45x | 10.03x | 118.15x |
| B-HNI | 1.32x | 5.04x | 183.16x |
| RII | 2.43x | 6.22x | 26.85x |
| Total | 1.65x | 4.6x | 53.68x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 61,72,156 | 12,20,36,508 | 549.16 |
| NII | 46,28,956 | 74,75,41,377 | 3,363.94 |
| Small NII | 15,42,985 | 18,23,10,174 | 820.4 |
| Big NII | 30,85,970 | 56,52,31,203 | 2,543.54 |
| RII | 1,08,00,896 | 29,00,31,012 | 1,305.14 |
| Total | 2,16,02,008 | 1,15,96,08,897 | 5,218.24 |
Company Details
- Hexagon Nutrition Ltd.
- 404 Global Chamber, Adarsh Nagar Link Road, Andheri (W), Mumbai, Maharashtra, 400053
- +91 22 6213 6710
- cs.hnpl@hexagonnutrition.com
- https://www.hexagonnutrition.com/
Registrar Details
- Kfin Technologies Ltd.
- 04067162222, 04079611000
- hexagon.ipo@kfintech.com
- https://ipostatus.kfintech.com/
Frequently Asked Questions
What does Hexagon Nutrition do?
What are the IPO dates for Hexagon Nutrition IPO?
What is the price band and minimum investment for Hexagon Nutrition IPO?
What is the Grey Market Premium (GMP) of Hexagon Nutrition IPO today?
Where will Hexagon Nutrition IPO be listed?
Hexagon Nutrition IPO News & Updates
Follow the latest updates for Hexagon Nutrition IPO, including grey market moves and allotment news.
Hexagon Nutrition IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Hexagon Nutrition IPO Details
Issue size, price, financials, and company info
Hexagon Nutrition IPO GMP
Live grey market premium and listing estimate
Hexagon Nutrition IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Hexagon Nutrition IPO Allotment
Allotment date, chances, and check by PAN
Hexagon Nutrition IPO Review
SWOT, strengths, risks, and IPO review
Hexagon Nutrition IPO FAQ
Common questions on dates, GMP, and allotment
Hexagon Nutrition IPO Registrar
Registrar website and how to check allotment
Hexagon Nutrition IPO Timeline
Open, close, allotment, and listing dates
Hexagon Nutrition IPO News
Updates, blogs, and latest IPO news
Sources
We match Hexagon Nutrition IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- Kfin Technologies Ltd.Official site to check allotment status for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.